FGF23 is a humoral factor produced by osteocytes and has been recognized as a significant predictor of life prognosis in patients undergoing dialysis [39], in whom it can induce cardiac hypertrophy [40], renal anemia [41], immunodeficiency [42], and chronic inflammation [43]. The gene discussed is FGF23; the disease is immune system disorder.